Cholera toxin chimera and its use as a staph vaccine

US9943582B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9943582-B2
Application numberUS-201414456090-A
CountryUS
Kind codeB2
Filing dateAug 11, 2014
Priority dateDec 16, 2011
Publication dateApr 17, 2018
Grant dateApr 17, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus . One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from S. aureus and an antigenic material from a S. aureus -specific polypeptide.

First claim

Opening claim text (preview).

The invention claimed is: 1. A chimeric protein comprising an amino acid sequence that is at least 90% identical to SEQ ID NO: 2 or an amino acid sequence that is at least 90% identical to SEQ ID NO: 3 and a truncated iron-regulated surface determinant A (IsdA) protein of S. aureus of SEQ ID NO: 4 as present within the amino acid sequence of SEQ ID NO: 5 or SEQ ID NO: 6. 2. The chimeric protein of claim 1 and an adjuvant protein selected from the group consisting of cholera toxin, heat-labile toxin and shiga toxin. 3. The chimeric protein of claim 2 , wherein said adjuvant protein is selected from the group consisting of cholera toxin subunit A (CTA), cholera toxin subunit B (CTB), heat-labile toxin subunit B and shiga toxin subunit B. 4. The chimeric protein of claim 3 , wherein said CTA adjuvant is CTA 2 or said CTB adjuvant is CTB. 5. The chimeric protein of claim 4 , wherein said CTA 2 has the amino acid sequence of SEQ ID NO: 2. 6. The chimeric protein of claim 4 , wherein said CTB has the amino acid sequence of SEQ ID NO: 3. 7. The chimeric protein of claim 5 , wherein the chimeric protein has the amino acid sequence of SEQ ID NO: 6. 8. The chimeric protein of claim 6 , wherein the chimeric protein has the amino acid sequence of SEQ ID NO: 5. 9. The chimeric protein of claim 2 , wherein the chimeric protein is a fusion protein. 10. An immunogenic composition comprising the chimeric protein of claim 1 . 11. An immunogenic composition comprising the chimeric protein of claim 7 . 12. An immunogenic composition comprising the chimeric protein of claim 8 .

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9943582B2 cover?
The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus . One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labil…
Who is the assignee on this patent?
Univ Boise State
What technology area does this patent fall under?
Primary CPC classification A61K39/085. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).